Follow
Rachel Totaram
Rachel Totaram
Verified email at ucf.edu
Title
Cited by
Cited by
Year
Comparing reasons for starting and stopping methadone, buprenorphine, and naltrexone treatment among a sample of white individuals with opioid use disorder
O Randall-Kosich, B Andraka-Christou, R Totaram, J Alamo, M Nadig
Journal of Addiction Medicine 14 (4), e44-e52, 2020
432020
Common themes in early state policy responses to substance use disorder treatment during COVID-19
B Andraka-Christou, K Bouskill, RL Haffajee, O Randall-Kosich, M Golan, ...
The American journal of drug and alcohol abuse 47 (4), 486-496, 2021
312021
Stigmatization of medications for opioid use disorder in 12-step support groups and participant responses
B Andraka-Christou, R Totaram, O Randall-Kosich
Substance Abuse 43 (1), 415-424, 2022
292022
Designing an “ideal” substance use disorder treatment center: Perspectives of people who have utilized medications for opioid use disorder
B Andraka-Christou, O Randall-Kosich, R Totaram
Qualitative Health Research 31 (3), 512-522, 2021
212021
Toward a typology of office-based buprenorphine treatment laws: themes from a review of state laws
B Andraka-Christou, AJ Gordon, K Bouskill, R Smart, O Randall-Kosich, ...
Journal of addiction medicine 16 (2), 192-207, 2022
192022
“We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs
TS Bartholomew, B Andraka-Cristou, RK Totaram, S Harris, ...
Harm reduction journal 19 (1), 133, 2022
142022
Beyond state scope of practice laws for advanced practitioners: Additional supervision requirements for buprenorphine prescribing
B Andraka-Christou, AJ Gordon, J Spetz, R Totaram, M Golan, ...
Journal of substance abuse treatment 138, 108715, 2022
132022
College students’ perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities
B Andraka-Christou, T Nguyen, S Harris, J Madeira, R Totaram, ...
The American Journal of Drug and Alcohol Abuse 46 (5), 589-603, 2020
122020
Systematic review and meta-analysis of changes in quality of life following initiation of buprenorphine for opioid use disorder
OK Golan, R Totaram, E Perry, K Fortson, R Rivera-Atilano, R Entress, ...
Drug and Alcohol Dependence 235, 109445, 2022
82022
A national survey of state laws regarding medications for opioid use disorder in problem-solving courts
B Andraka-Christou, O Randall-Kosich, M Golan, R Totaram, B Saloner, ...
Health & Justice 10 (1), 14, 2022
72022
Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019
B Andraka-Christou, O Golan, R Totaram, M Ohama, B Saloner, ...
Annals of Medicine 55 (1), 514-520, 2023
62023
Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington DC
B Andraka-Christou, B Saloner, AJ Gordon, R Totaram, O Randall-Kosich, ...
The American journal of drug and alcohol abuse 48 (4), 492-503, 2022
62022
Inequities in access to medical care among adults diagnosed with diabetes: comparisons between the US population and a sample of US-Residing marshallese islanders
SD Towne, KHK Yeary, MR Narcisse, C Long, Z Bursac, R Totaram, ...
Journal of racial and ethnic health disparities 8, 375-383, 2021
62021
Barriers to medications for opioid use disorder in the court system: provider availability, provider “trustworthiness,” and cost
FZ Ahmed, B Andraka-Christou, MH Clark, R Totaram, DN Atkins, ...
Health & justice 10 (1), 24, 2022
32022
Comprehensive analysis of discharge reasons from methadone outpatient treatment programs
B Andraka‐Christou, R Totaram, TD Nguyen
The American Journal on Addictions 31 (6), 508-516, 2022
22022
A pilot study of US college students’ 12-step orientation and the relationship with medications for opioid use disorder
B Andraka-Christou, T Nguyen, S Harris, J Madeira, R Totaram, ...
Journal of American College Health 70 (8), 2383-2391, 2022
12022
Harm reduction policy support among students at two US universities
B Andraka-Christou, T Nguyen, S Harris, DN Atkins, R Totaram, O Golan, ...
Substance Use & Misuse 57 (8), 1185-1195, 2022
12022
Impact of COVID-19 on Florida family dependency drug courts
OK Golan, FZ Ahmed, B Andraka-Christou, R Totaram, Y Asi, D Atkins
Health & Justice 12 (1), 4, 2024
2024
Problem-Solving Court Staff Preferences for Educational Videos about Medications for Opioid Use Disorder
B Andraka-Christou, YM Asi, R Totaram, H Matusow
Substance Use & Misuse 58 (12), 1550-1559, 2023
2023
Operationalizing person-centered care in residential substance use disorder treatment
B Andraka-Christou, OK Golan, R Totaram, MC Shields, K Cortelyou, ...
Journal of Addictive Diseases, 1-16, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20